Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

China Biosimilar Drug Industry 2016

  • QYR678363
  • 164 Pages
  • September 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
The China Biosimilar Drug Industry 2016 is a professional and in-depth study on the current state of the Biosimilar Drug industry.

Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The biosimilar drug market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status.

Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin by regions (North China, East China, etc.), and other regions can be added.

Then, the report focuses on China major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What’s more, the biosimilar drug industry development trends and marketing channels are analyzed.

Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.

In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table of Contents

1 Industry Overview 1

1.1 Definition and Specifications of Biosimilar Drug 1

1.2 Classification of Biosimilar Drug 2

1.2.1 Injection 2

1.2.2 Tablets 2

1.2.3 Others 2

1.3 Applications of Biosimilar Drug 2

1.3.1 Ankylosing Spondylitis 2

1.3.2 Tumor 3

1.3.3 Rheumatoid Arthrtis 3

1.3.4 Cardiovascular 3

1.4 Industry Chain Structure of Biosimilar Drug 4

1.5 Industry Policy Analysis of Biosimilar Drug 4

1.6 Industry News Analysis of Biosimilar Drug 5

2 Manufacturing Cost Structure Analysis of Biosimilar Drug 7

2.1 Bill of Materials (BOM) of Biosimilar Drug 7

2.2 Labor Cost Analysis of Biosimilar Drug 7

2.3 Depreciation Cost Analysis of Biosimilar Drug 8

2.4 Manufacturing Cost Structure Analysis of Biosimilar Drug 8

2.5 Manufacturing Process Analysis of Biosimilar Drug 9

3 Technical Data and Manufacturing Plants Analysis of Biosimilar Drug 10

3.1 Capacity and Commercial Production Date of China Key Manufacturers in 2015 10

3.2 Manufacturing Plants Distribution of China Key Biosimilar Drug Manufacturers in 2015 10

3.3 Product, R&D Status and Technology Source of China Biosimilar Drug Key Manufacturers in 2015 11

3.4 Raw Materials Sources Analysis of China Biosimilar Drug Key Manufacturers in 2015 13

4 Capacity, Production and Revenue Analysis of Biosimilar Drug by Regions, Types and Manufacturers 14

4.1 China Capacity, Production and Revenue of Biosimilar Drug by Regions 2011-2016 14

4.2 China and Major Regions Capacity, Production, Revenue and Growth Rate of Biosimilar Drug 2011-2016 24

4.3 China Production and Revenue of Biosimilar Drug by Types 2011-2016 29

4.4 China Capacity, Production and Revenue of Biosimilar Drug by Manufacturers 2011-2016 36

5 Price, Cost, Gross and Gross Margin Analysis of Biosimilar Drug by Regions, Types and Manufacturers 48

5.1 Price, Cost, Gross and Gross Margin Analysis of Biosimilar Drug by Regions 2011-2016 48

5.2 Price and Gross Margin Analysis of Biosimilar Drug by Types 2011-2016 51

5.3 Price, Cost, Gross and Gross Margin Analysis of Biosimilar Drug by Manufacturers 2011-2016 52

6 Consumption Volume, Consumption Value and Sale Price Analysis of Biosimilar Drug by Regions, Types and Applications 57

6.1 China Consumption Volume and Consumption Value of Biosimilar Drug by Regions 2011-2016 57

6.2 China and Major Regions Consumption Volume, Consumption Value and Growth Rate of Biosimilar Drug 2011-2016 65

6.3 China Consumption Volume and Consumption Value of Biosimilar Drug by Applications 2011-2016 68

6.4 Sale Price of Biosimilar Drug by Regions 2011-2016 75

6.5 Sale Price of Biosimilar Drug by Applications 2011-2016 75

6.6 Market Share Analysis of Biosimilar Drug by Different Sale Price Levels 77

7 Supply, Import, Export and Consumption Analysis of Biosimilar Drug 78

7.1 Supply, Consumption and Gap of Biosimilar Drug 2011-2016 78

7.2 China Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Biosimilar Drug 2011-2016 79

7.3 North China Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Biosimilar Drug 2011-2016 80

7.4 East China Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Biosimilar Drug 2011-2016 80

8 Analysis of Biosimilar Drug Industry Key Manufacturers 82

8.1 CP Guojian 82

8.1.1 Company Profile 82

8.1.2 Product Picture and Specifications 83

8.1.3 Capacity, Production, Price, Cost, Gross, and Revenue 84

8.1.4 Contact Information 86

8.2 Biotech 86

8.2.1 Company Profile 86

8.2.2 Product Picture and Specifications 87

8.2.3 Capacity, Production, Price, Cost, Gross, and Revenue 88

8.2.4 Contact Information 89

8.3 Celgen 89

8.3.1 Company Profile 89

8.3.2 Product Picture and Specifications 91

8.3.3 Capacity, Production, Price, Cost, Gross, and Revenue 92

8.3.4 Contact Information 94

8.4 Henlius Biotech 94

8.4.1 Company Profile 94

8.4.2 Product Picture and Specifications 95

8.4.3 Capacity, Production, Price, Cost, Gross, and Revenue 96

8.4.4 Contact Information 98

8.5 Amgen 98

8.5.1 Company Profile 98

8.5.2 Product Picture and Specifications 99

8.5.3 Contact Information 100

8.6 Eli Lilly 100

8.6.1 Company Profile 100

8.6.2 Product Picture and Specifications 102

8.6.3 Contact Information 102

8.7 Novartis 103

8.7.1 Company Profile 103

8.7.2 Product Picture and Specifications 104

8.7.3 Contact Information 104

8.8 Changchun High Tech 105

8.8.1 Company Profile 105

8.8.2 Contact Information 106

8.9 Innovent 106

8.9.1 Company Profile 106

8.9.2 Product Picture and Specification 107

8.9.3 Contact Information 108

9 Marketing Trader or Distributor Analysis of Biosimilar Drug 109

9.1 Marketing Channels Status of Biosimilar Drug 109

9.2 Traders or Distributors of Biosimilar Drug with Contact Information 109

9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Biosimilar Drug 111

9.4 China Import, Export and Trade Analysis of Biosimilar Drug 111

10 Development Trend of Analysis of Biosimilar Drug 112

10.1 Capacity, Production and Revenue Forecast of Biosimilar Drug by Regions and Types 112

10.1.1 China Capacity, Production and Revenue of Biosimilar Drug by Regions 2016-2021 112

10.1.2 China and Major Regions Capacity, Production, Revenue and Growth Rate of Biosimilar Drug 2016-2021 115

10.1.3 China Capacity, Production and Revenue of Biosimilar Drug by Types 2016-2021 119

10.2 Consumption Volume and Consumption Value Forecast of Biosimilar Drug by Regions, Types and Applications 121

10.2.1 China Consumption Volume and Consumption Value of Biosimilar Drug by Regions 2016-2021 121

10.2.2 China and Major Regions Consumption Volume, Consumption Value and Growth Rate of Biosimilar Drug 2016-2021 125

10.2.3 China Consumption Volume and Consumption Value of Biosimilar Drug by Applications 2016-2021 128

10.3 Supply, Import, Export and Consumption Forecast of Biosimilar Drug 130

10.3.1 Supply, Consumption and Gap of Biosimilar Drug 2016-2021 130

10.3.2 China Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Biosimilar Drug 2016-2021 131

10.3.3 North China Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Biosimilar Drug 2016-2021 132

10.3.4 East China Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Biosimilar Drug 2016-2021 132

11 Industry Chain Suppliers of Biosimilar Drug with Contact Information 134

11.1 Major Raw Materials Suppliers of Biosimilar Drug with Contact Information 134

11.2 Manufacturing Equipment Suppliers of Biosimilar Drug with Contact Information 135

11.3 Major Players of Biosimilar Drug with Contact Information 136

11.4 Key Consumers of Biosimilar Drug with Contact Information 137

11.5 Supply Chain Relationship Analysis of Biosimilar Drug 138

12 New Project Investment Feasibility Analysis of Biosimilar Drug 139

12.1 New Project SWOT Analysis of Biosimilar Drug 139

12.2 New Project Investment Feasibility Analysis of Biosimilar Drug 140

13 Conclusion of the China Biosimilar Drug Industry 2016 141

Tables and Figures

Figure Picture of Biosimilar Drug 1

Table Product Specifications of Biosimilar Drug 1

Figure Industry Chain Structure of Biosimilar Drug 4

Table Industry Policy of Biosimilar Drug 4

Table Industry News List of Biosimilar Drug 5

Table Bill of Materials (BOM) of Biosimilar Drug 7

Figure APAC Overview of Average Monthly Labor Cost 7

Table Depreciation Cost of Biosimilar Drug 8

Table Manufacturing Cost Structure Analysis of Biosimilar Drug in 2015 8

Figure Manufacturing Process Analysis of Biosimilar Drug 9

Table Capacity (K DDD) and Commercial Production Date of China Biosimilar Drug Key Manufacturers in 2015 10

Table Manufacturing Plants Distribution of China Key Biosimilar Drug Manufacturers in 2015 10

Table Product of China Biosimilar Drug Key Manufacturers in 2015 11

Table R&D Status and Technology Source of China Biosimilar Drug Key Manufacturers in 2015 11

Table R&D Status of Chinese Biosimilar Drug by Other Key Players at the End of 2015 11

Table R&D Status of Chinese Biosimilar Drugs by Products in China at the End of 2015 13

Table Raw Materials Sources Analysis of China and China Biosimilar Drug Key Manufacturers in 2015 13

Table China Capacity (K DDD) of Biosimilar Drug by Regions 2011-2016 14

Figure China Capacity Market Share of Biosimilar Drug by Regions in 2011 14

Figure China Capacity Market Share of Biosimilar Drug by Regions in 2012 15

Figure China Capacity Market Share of Biosimilar Drug by Regions in 2013 15

Figure China Capacity Market Share of Biosimilar Drug by Regions in 2014 16

Figure China Capacity Market Share of Biosimilar Drug by Regions in 2015 16

Figure China Capacity Market Share of Biosimilar Drug by Regions in 2016 17

Table China Production (K DDD) of Biosimilar Drug by Regions 2011-2016 17

Figure China Production Market Share of Biosimilar Drug by Regions in 2011 18

Figure China Production Market Share of Biosimilar Drug by Regions in 2012 18

Figure China Production Market Share of Biosimilar Drug by Regions in 2013 19

Figure China Production Market Share of Biosimilar Drug by Regions in 2014 19

Figure China Production Market Share of Biosimilar Drug by Regions in 2015 20

Figure China Production Market Share of Biosimilar Drug by Regions in 2016 20

Table China Revenue (M $) of Biosimilar Drug by Regions 2011-2016 21

Figure China Revenue Market Share of Biosimilar Drug by Regions in 2011 21

Figure China Revenue Market Share of Biosimilar Drug by Regions in 2012 22

Figure China Revenue Market Share of Biosimilar Drug by Regions in 2013 22

Figure China Revenue Market Share of Biosimilar Drug by Regions in 2014 23

Figure China Revenue Market Share of Biosimilar Drug by Regions in 2015 23

Figure China Revenue Market Share of Biosimilar Drug by Regions in 2016 24

Figure China Capacity (K DDD), Production (K DDD) and Growth Rate of Biosimilar Drug 2011-2016 24

Figure China Capacity Utilization Rate of Biosimilar Drug 2011-2016 25

Figure China Revenue (M $) and Growth Rate of Biosimilar Drug 2011-2016 25

Figure North China Capacity (K DDD), Production (K DDD) and Growth Rate of Biosimilar Drug 2011-2016 26

Figure North China Capacity Utilization Rate of Biosimilar Drug 2011-2016 26

Figure North China Revenue (M $) and Growth Rate of Biosimilar Drug 2011-2016 27

Figure East China Capacity (K DDD), Production (K DDD) and Growth Rate of Biosimilar Drug 2011-2016 27

Figure East China Capacity Utilization Rate of Biosimilar Drug 2011-2016 28

Figure East China Revenue (M $) and Growth Rate of Biosimilar Drug 2011-2016 28

Table China Production (K DDD) of Biosimilar Drug by Types 2011-2016 29

Figure China Production Market Share of Biosimilar Drug by Types in 2011 29

Figure China Production Market Share of Biosimilar Drug by Types in 2012 30

Figure China Production Market Share of Biosimilar Drug by Types in 2013 30

Figure China Production Market Share of Biosimilar Drug by Types in 2014 31

Figure China Production Market Share of Biosimilar Drug by Types in 2015 31

Figure China Production Market Share of Biosimilar Drug by Types in 2016 32

Table China Revenue (M $) of Biosimilar Drug by Types 2011-2016 32

Figure China Revenue Market Share of Biosimilar Drug by Types in 2011 33

Figure China Revenue Market Share of Biosimilar Drug by Types in 2012 33

Figure China Revenue Market Share of Biosimilar Drug by Types in 2013 34

Figure China Revenue Market Share of Biosimilar Drug by Types in 2014 34

Figure China Revenue Market Share of Biosimilar Drug by Types in 2015 35

Figure China Revenue Market Share of Biosimilar Drug by Types in 2016 35

Table China Major Manufacturers Capacity (K DDD) of Biosimilar Drug 2011-2016 36

Table China Capacity Market Share of Biosimilar Drug Major Manufacturers 2011-2016 36

Figure China Capacity Market Share of Biosimilar Drug Major Manufacturers in 2011 37

Figure China Capacity Market Share of Biosimilar Drug Major Manufacturers in 2012 37

Figure China Capacity Market Share of Biosimilar Drug Major Manufacturers in 2013 38

Figure China Capacity Market Share of Biosimilar Drug Major Manufacturers in 2014 38

Figure China Capacity Market Share of Biosimilar Drug Major Manufacturers in 2015 39

Figure China Capacity Market Share of Biosimilar Drug Major Manufacturers in 2016 39

Table China Major Manufacturers Production (K DDD) of Biosimilar Drug 2011-2016 40

Table China Production Market Share of Biosimilar Drug Major Manufacturers 2011-2016 40

Figure China Production Market Share of Biosimilar Drug Major Manufacturers in 2011 41

Figure China Production Market Share of Biosimilar Drug Major Manufacturers in 2012 41

Figure China Production Market Share of Biosimilar Drug Major Manufacturers in 2013 42

Figure China Production Market Share of Biosimilar Drug Major Manufacturers in 2014 42

Figure China Production Market Share of Biosimilar Drug Major Manufacturers in 2015 43

Figure China Production Market Share of Biosimilar Drug Major Manufacturers in 2016 43

Table China Major Manufacturers Revenue (M $) of Biosimilar Drug 2011-2016 44

Table China Revenue Market Share of Biosimilar Drug Major Manufacturers 2011-2016 44

Figure China Revenue Market Share of Biosimilar Drug Major Manufacturers in 2011 45

Figure China Revenue Market Share of Biosimilar Drug Major Manufacturers in 2012 45

Figure China Revenue Market Share of Biosimilar Drug Major Manufacturers in 2013 46

Figure China Revenue Market Share of Biosimilar Drug Major Manufacturers in 2014 46

Figure China Revenue Market Share of Biosimilar Drug Major Manufacturers in 2015 47

Figure China Revenue Market Share of Biosimilar Drug Major Manufacturers in 2016 47

Table Price ($/DDD) of Biosimilar Drug by Regions 2011-2016 48

Figure Price ($/DDD) of Biosimilar Drug by Regions in 2015 48

Table Cost ($/DDD) of Biosimilar Drug by Regions 2011-2016 49

Figure Cost ($/DDD) of Biosimilar Drug by Regions in 2015 49

Table Gross ($/DDD) of Biosimilar Drug by Regions 2011-2016 49

Figure Gross ($/DDD) of Biosimilar Drug by Regions in 2015 50

Table Gross Margin of Biosimilar Drug by Regions 2011-2016 50

Figure Gross Margin of Biosimilar Drug by Regions in 2015 50

Table Price ($/DDD) of Biosimilar Drug by Types 2011-2016 51

Figure Price ($/DDD) of Biosimilar Drug by Types in 2015 51

Table Gross Margin of Biosimilar Drug by Types 2011-2016 51

Figure Gross Margin of Biosimilar Drug by Types in 2015 52

Table Price ($/DDD) of Biosimilar Drug by Manufacturers 2011-2016 52

Figure Price ($/DDD) of Biosimilar Drug by Manufacturers in 2015 53

Table Cost ($/DDD) of Biosimilar Drug by Manufacturers 2011-2016 53

Figure Cost ($/DDD) of Biosimilar Drug by Manufacturers in 2015 54

Table Gross ($/DDD) of Biosimilar Drug by Manufacturers 2011-2016 54

Figure Gross ($/DDD) of Biosimilar Drug by Manufacturers in 2015 55

Table Gross Margin of Biosimilar Drug by Manufacturers 2011-2016 55

Figure Gross Margin ($/DDD) of Biosimilar Drug by Manufacturers in 2015 56

Table China Consumption Volume (K DDD) of Biosimilar Drug by Regions 2011-2016 57

Figure China Consumption Volume Market Share of Biosimilar Drug by Regions in 2011 58

Figure China Consumption Volume Market Share of Biosimilar Drug by Regions in 2012 58

Figure China Consumption Volume Market Share of Biosimilar Drug by Regions in 2013 59

Figure China Consumption Volume Market Share of Biosimilar Drug by Regions in 2014 59

Figure China Consumption Volume Market Share of Biosimilar Drug by Regions in 2015 60

Figure China Consumption Volume Market Share of Biosimilar Drug by Regions in 2016 60

Table China Consumption Value (M $) of Biosimilar Drug by Regions 2011-2016 61

Figure China Consumption Value Market Share of Biosimilar Drug by Regions in 2011 61

Figure China Consumption Value Market Share of Biosimilar Drug by Regions in 2012 62

Figure China Consumption Value Market Share of Biosimilar Drug by Regions in 2013 62

Figure China Consumption Value Market Share of Biosimilar Drug by Regions in 2014 63

Figure China Consumption Value Market Share of Biosimilar Drug by Regions in 2015 63

Figure China Consumption Value Market Share of Biosimilar Drug by Regions in 2016 64

Figure China Consumption Volume (K DDD) and Growth Rate of Biosimilar Drug 2011-2016 65

Figure China Consumption Value (M $) and Growth Rate of Biosimilar Drug 2011-2016 65

Figure North China Consumption Volume (K DDD) and Growth Rate of Biosimilar Drug 2011-2016 66

Figure North China Consumption Value (M $) and Growth Rate of Biosimilar Drug 2011-2016 66

Figure East China Consumption Volume (K DDD) and Growth Rate of Biosimilar Drug 2011-2016 67

Figure East China Consumption Value (M $) and Growth Rate of Biosimilar Drug 2011-2016 67

Table China Consumption Volume (K DDD) of Biosimilar Drug by Applications 2011-2016 68

Figure China Consumption Volume Market Share of Biosimilar Drug by Applications in 2011 68

Figure China Consumption Volume Market Share of Biosimilar Drug by Applications in 2012 69

Figure China Consumption Volume Market Share of Biosimilar Drug by Applications in 2013 69

Figure China Consumption Volume Market Share of Biosimilar Drug by Applications in 2014 70

Figure China Consumption Volume Market Share of Biosimilar Drug by Applications in 2015 70

Figure China Consumption Volume Market Share of Biosimilar Drug by Applications in 2016 71

Table China Consumption Value (M $) of Biosimilar Drug by Applications 2011-2016 71

Figure China Consumption Value Market Share of Biosimilar Drug by Applications in 2011 72

Figure China Consumption Value Market Share of Biosimilar Drug by Applications in 2012 72

Figure China Consumption Value Market Share of Biosimilar Drug by Applications in 2013 73

Figure China Consumption Value Market Share of Biosimilar Drug by Applications in 2014 73

Figure China Consumption Value Market Share of Biosimilar Drug by Applications in 2015 74

Figure China Consumption Value Market Share of Biosimilar Drug by Applications in 2016 74

Table Sale Price ($/DDD) of Biosimilar Drug by Regions 2011-2016 75

Figure Sale Price ($/DDD) of Biosimilar Drug by Regions in 2015 75

Table Sale Price ($/DDD) of Biosimilar Drug by Applications 2011-2016 75

Figure Sale Price ($/DDD) of Biosimilar Drug by Application in 2015 76

Table Market Share of Biosimilar Drug by Different Sale Price Levels 77

Table China Supply, Consumption and Gap of Biosimilar Drug 2011-2016 (K DDD) 78

Table North China Supply, Consumption and Gap of Biosimilar Drug 2011-2016 (K DDD) 78

Table East China Supply, Consumption and Gap of Biosimilar Drug 2011-2016 (K DDD) 78

Table China Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Revenue (M $) and Gross Margin of Biosimilar Drug 2011-2016 79

Table China Supply, Import, Export and Consumption of Biosimilar Drug 2011-2016 (K DDD) 79

Table North China Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Revenue (M $) and Gross Margin of Biosimilar Drug 2011-2016 80

Table East China Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Revenue (M $) and Gross Margin of Biosimilar Drug 2011-2016 80

Table CP Guojian Company Profile 82

Figure Biosimilar Drug Picture and Specifications of CP Guojian 83

Table Biosimilar Drug Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Gross ($/DDD), Revenue (M $)and Gross Margin of CP Guojian 2011-2016E 84

Figure Biosimilar Drug Capacity (K DDD), Production (K DDD) and Growth Rate of CP Guojian 2011-2016E 85

Figure Biosimilar Drug Production (K DDD) and China Market Share of CP Guojian 2011-2016E 85

Table Biotech Company Profile 86

Table Biosimilar Drug Picture and Specifications of Biotech 87

Table Biosimilar Drug Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Gross ($/DDD), Revenue (M $)and Gross Margin of Biotech 2011-2016E 88

Figure Biosimilar Drug Capacity (K DDD), Production (K DDD) and Growth Rate of Biotech 2011-2016E 88

Figure Biosimilar Drug Production (K DDD) and China Market Share of Biotech 2011-2016E 89

Table Celgen Company Profile 89

Figure Biosimilar Drug Picture and Specifications of Celgen 91

Table Biosimilar Drug Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Gross ($/DDD), Revenue (M $)and Gross Margin of Celgen 2011-2016E 92

Figure Biosimilar Drug Capacity (K DDD), Production (K DDD) and Growth Rate of Celgen 2011-2016E 93

Figure Biosimilar Drug Production (K DDD) and China Market Share of Celgen 2011-2016E 93

Table Henlius Biotech Company Profile 94

Figure Biosimilar Drug Picture and Specifications of Henlius Biotech 95

Table Biosimilar Drug Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Gross ($/DDD), Revenue (M $)and Gross Margin of Henlius Biotech 2011-2016E 96

Figure Biosimilar Drug Capacity (K DDD), Production (K DDD) and Growth Rate of Henlius Biotech 2011-2016E 97

Figure Biosimilar Drug Production (K DDD) and China Market Share of Henlius Biotech 2011-2016E 97

Table Amgen Company Profile 98

Figure Biosimilar Drug Picture and Specifications of Amgen 99

Table Eli Lilly Company Profile 100

Figure Biosimilar Drug Picture and Specifications of Eli Lilly 102

Table Novartis Company Profile 103

Figure Biosimilar Drug Picture and Specifications of Novartis 104

Table Changchun High Tech Company Profile 105

Table Innovent Company Profile 106

Figure Marketing Channels Status of Biosimilar Drug in 2015 109

Table Traders or Distributors of Biosimilar Drug with Contact Information 109

Table Ex-work Price, Channel Price and End Buyer Price of Biosimilar Drug ($/DDD) in 2011-2016E 111

Table China Import, Export, and Trade of Biosimilar Drug (K DDD) 111

Table China Capacity (K DDD) of Biosimilar Drug by Regions 2016-2021 112

Figure China Capacity Market Share of Biosimilar Drug by Regions in 2021 113

Table China Production (K DDD) of Biosimilar Drug by Regions 2016-2021 113

Figure China Production Market Share of Biosimilar Drug by Regions in 2021 114

Table China Revenue (M $) of Biosimilar Drug by Regions 2016-2021 114

Figure China Revenue Market Share of Biosimilar Drug by Regions in 2021 115

Figure China Capacity (K DDD), Production (K DDD) and Growth Rate of Biosimilar Drug 2016-2021 115

Figure China Capacity Utilization Rate of Biosimilar Drug 2016-2021 116

Figure China Revenue (M $) and Growth Rate of Biosimilar Drug 2016-2021 116

Figure North China Capacity (K DDD), Production (K DDD) and Growth Rate of Biosimilar Drug 2016-2021 117

Figure North China Capacity Utilization Rate of Biosimilar Drug 2016-2021 117

Figure North China Revenue (M $) and Growth Rate of Biosimilar Drug 2016-2021 118

Figure East China Capacity (K DDD), Production (K DDD) and Growth Rate of Biosimilar Drug 2016-2021 118

Figure East China Capacity Utilization Rate of Biosimilar Drug 2016-2021 119

Figure East China Revenue (M $) and Growth Rate of Biosimilar Drug 2016-2021 119

Table China Production (K DDD) of Biosimilar Drug by Types 2016-2021 119

Figure China Production Market Share of Biosimilar Drug by Types in 2021 120

Table China Revenue (M $) of Biosimilar Drug by Types 2016-2021 120

Figure China Revenue Market Share of Biosimilar Drug by Types in 2021 121

Table China Consumption Volume (K DDD) of Biosimilar Drug by Regions 2016-2021 121

Figure China Consumption Volume Market Share of Biosimilar Drug by Regions in 2016 122

Figure China Consumption Volume Market Share of Biosimilar Drug by Regions in 2021 122

Table China Consumption Value (M $) of Biosimilar Drug by Regions 2016-2021 123

Figure China Consumption Value Market Share of Biosimilar Drug by Regions in 2016 123

Figure China Consumption Value Market Share of Biosimilar Drug by Regions in 2021 124

Figure China Consumption Volume (K DDD) and Growth Rate of Biosimilar Drug 2016-2021 125

Figure China Consumption Value (M $) and Growth Rate of Biosimilar Drug 2016-2021 125

Figure North China Consumption Volume (K DDD) and Growth Rate of Biosimilar Drug 2016-2021 126

Figure North China Consumption Value (M $) and Growth Rate of Biosimilar Drug 2016-2021 126

Figure East China Consumption Volume (K DDD) and Growth Rate of Biosimilar Drug 2016-2021 127

Figure East China Consumption Value (M $) and Growth Rate of Biosimilar Drug 2016-2021 127

Table China Consumption Volume (K DDD) of Biosimilar Drug by Applications 2016-2021 128

Figure China Consumption Volume Market Share of Biosimilar Drug by Applications in 2021 128

Table China Consumption Value (M $) of Biosimilar Drug by Applications 2016-2021 129

Figure China Consumption Value Market Share of Biosimilar Drug by Applications in 2021 129

Table China Supply, Consumption and Gap of Biosimilar Drug 2016-2021 (K DDD) 130

Table North China Supply, Consumption and Gap of Biosimilar Drug 2016-2021 (K DDD) 130

Table East China Supply, Consumption and Gap of Biosimilar Drug 2016-2021 (K DDD) 130

Table China Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Revenue (M $) and Gross Margin of Biosimilar Drug 2016-2021 131

Table China Supply, Import, Export and Consumption of Biosimilar Drug 2016-2021 (K DDD) 131

Table North China Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Revenue (M $) and Gross Margin of Biosimilar Drug 2016-2021 132

Table East China Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Revenue (M $) and Gross Margin of Biosimilar Drug 2016-2021 132

Table Major Raw Materials Suppliers of Biosimilar Drug with Contact Information 134

Table Manufacturing Equipment Suppliers of Biosimilar Drug with Contact Information 135

Table Major Players of Biosimilar Drug with Contact Information 136

Table Key Consumers of Biosimilar Drug with Contact Information 137

Figure Supply Chain Relationship Analysis of Biosimilar Drug 138

Table New Project SWOT Analysis of Biosimilar Drug 139

Table New Project Investment Feasibility Analysis of Biosimilar Drug 140

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390